Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bellón T[au]:

Search results

Items: 1 to 50 of 83

1.

Lymphocyte Transformation Test (LTT) in Allergy to Benznidazole: A Promising Approach.

Marques-Mejías MA, Cabañas R, Ramírez E, Domínguez-Ortega J, Fiandor A, Trigo E, Quirce S, Bellón T.

Front Pharmacol. 2019 May 21;10:469. doi: 10.3389/fphar.2019.00469. eCollection 2019.

2.

Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.

Bellón T.

Drug Saf. 2019 Apr 24. doi: 10.1007/s40264-019-00825-2. [Epub ahead of print] Review.

PMID:
31020549
3.

HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS/TEN in Europeans.

Mockenhaupt M, Wang CW, Hung SI, Sekula P, Schmidt AH, Pan RY, Chen CB, Dunant A, Gouvello SL, Schumacher M, Valeyrie-Allanore L, Bellon T, Kardaun SH, Jan YS, Chung WH, Roujeau JC; RegiSCAR group.

Allergy. 2019 Apr 11. doi: 10.1111/all.13821. [Epub ahead of print] No abstract available.

PMID:
30972788
4.

Oseltamivir-induced toxic epidermal necrolysis in a patient with Cushing's disease.

González-Ramos J, Lamas C, Bellón T, Ruiz-Bravo E, Ramírez E, Lerma V, Lecumberri B.

Indian J Dermatol Venereol Leprol. 2019 Jan 25. doi: 10.4103/ijdvl.IJDVL_53_18. [Epub ahead of print]

5.

Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.

Carr DF, Wang CW, Bellón T, Ressel L, Nwikue G, Shrivastava V, Bergfeld W, Jorgensen AL, Chung WH, Pirmohamed M.

Br J Dermatol. 2019 Jan 5. doi: 10.1111/bjd.17610. [Epub ahead of print]

PMID:
30613954
6.

Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study.

Rodríguez-Martín S, Martín-Merino E, Lerma V, Rodríguez-Miguel A, González O, González-Herrada C, Ramírez E, Bellón T, de Abajo FJ.

Eur J Clin Pharmacol. 2019 Feb;75(2):237-246. doi: 10.1007/s00228-018-2569-3. Epub 2018 Oct 8.

PMID:
30298362
7.

Active surveillance of severe cutaneous adverse reactions: A case-population approach using a registry and a health care database.

Rodríguez-Martín S, Martín-Merino E, Lerma V, Rodríguez-Miguel A, González O, González-Herrada C, Ramírez E, Bellón T, de Abajo FJ.

Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1042-1050. doi: 10.1002/pds.4622. Epub 2018 Jul 27.

PMID:
30051945
8.

NSAIDs hypersensitivity: questions not resolved.

Blanca-Lopez N, Somoza-Alvarez ML, Bellon T, Amo G, Canto G, Blanca M.

Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):291-301. doi: 10.1097/ACI.0000000000000454. Review.

PMID:
29878898
9.

Prominent Levels of the Profibrotic Chemokine CCL18 during Peritonitis: In Vitro Downregulation by Vitamin D Receptor Agonists.

Ossorio M, Martínez V, Bajo MA, Del Peso G, Castro MJ, Romero S, Selgas R, Bellón T.

Biomed Res Int. 2018 Apr 4;2018:6415892. doi: 10.1155/2018/6415892. eCollection 2018.

10.

Overlap Between DRESS Syndrome and Exanthema Induced by Sulfadiazine in a Patient Treated With Sulfamethoxazole: Utility of the Lymphocyte Transformation Test for Identification of the Culprit Drug.

Monge-Ortega OP, Cabañas R, Fiandor A, Domínguez-Ortega J, González-Muñoz M, Quirce S, Lluch-Bernal M, Bellón T.

J Investig Allergol Clin Immunol. 2018 Apr;28(2):132-134. doi: 10.18176/jiaci.0220. No abstract available.

11.

Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment.

Cabañas R, Calderón O, Ramírez E, Fiandor A, Caballero T, Heredia R, Herranz P, Madero R, Quirce S, Bellón T.

Clin Exp Allergy. 2018 Mar;48(3):325-333. doi: 10.1111/cea.13076. Epub 2018 Jan 19.

PMID:
29265576
12.

Cytomegalovirus infection after kidney transplantation and long-term graft loss.

López-Oliva MO, Flores J, Madero R, Escuin F, Santana MJ, Bellón T, Selgas R, Jiménez C.

Nefrologia. 2017 Sep - Oct;37(5):515-525. doi: 10.1016/j.nefro.2016.11.018. English, Spanish.

13.

Mechanisms Involved in Hypersensitivity Reactions to Polysulfone Hemodialysis Membranes.

Rodríguez-Sanz A, Sánchez-Villanueva R, Domínguez-Ortega J, Fiandor AM, Ruiz MP, Trocoli F, Díaz-Tejeiro R, Cadenillas C, González E, Martínez V, López-Trascasa M, Quirce S, Selgas R, Bellón T.

Artif Organs. 2017 Nov;41(11):E285-E295. doi: 10.1111/aor.12954. Epub 2017 Jul 19.

PMID:
28722144
14.

Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches.

González-Herrada C, Rodríguez-Martín S, Cachafeiro L, Lerma V, González O, Lorente JA, Rodríguez-Miguel A, González-Ramos J, Roustan G, Ramírez E, Bellón T, de Abajo FJ; PIELenRed Therapeutic Management Working Group.

J Invest Dermatol. 2017 Oct;137(10):2092-2100. doi: 10.1016/j.jid.2017.05.022. Epub 2017 Jun 17. Review.

15.

Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis.

Ossorio M, Bajo MA, Del Peso G, Martínez V, Fernández M, Castro MJ, Rodríguez-Sanz A, Madero R, Bellón T, Selgas R.

PLoS One. 2017 Apr 17;12(4):e0175835. doi: 10.1371/journal.pone.0175835. eCollection 2017.

16.

Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

Su SC, Mockenhaupt M, Wolkenstein P, Dunant A, Le Gouvello S, Chen CB, Chosidow O, Valeyrie-Allanore L, Bellon T, Sekula P, Wang CW, Schumacher M, Kardaun SH, Hung SI, Roujeau JC, Chung WH.

J Invest Dermatol. 2017 May;137(5):1065-1073. doi: 10.1016/j.jid.2016.11.034. Epub 2016 Dec 21.

17.

Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population.

Ramírez E, Bellón T, Tong HY, Borobia AM, de Abajo FJ, Lerma V, Moreno Hidalgo MA, Castañer JL, Cabañas R, Fiandor A, González-Ramos J, Herranz P, Cachafeiro L, González-Herrada C, González O, Aramburu JA, Laosa O, Hernández R, Carcas AJ, Frías J.

Pharmacol Res. 2017 Jan;115:168-178. doi: 10.1016/j.phrs.2016.11.027. Epub 2016 Nov 22.

PMID:
27888155
18.

Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital.

Ramírez E, Medrano-Casique N, Tong HY, Bellón T, Cabañas R, Fiandor A, González-Ramos J, Herranz P, Trigo E, Muñoz M, Borobia AM, Carcas AJ, Frías J.

Br J Clin Pharmacol. 2017 Feb;83(2):400-415. doi: 10.1111/bcp.13096. Epub 2016 Oct 12.

19.

Positive Allergy Study (Intradermal, Patch, and Lymphocyte Transformation Tests) in a Case of Isoniazid-Induced DRESS.

Arruti N, Villarreal O, Bernedo N, Audicana MT, Velasco M, Uriel O, Martinez A, Bellón T.

J Investig Allergol Clin Immunol. 2016;26(2):119-20. doi: 10.18176/jiaci.0025. No abstract available.

20.

The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome.

Bellón T, Ramírez E, Borobia AM, Lerma V, Moreno-Hidalgo MA, Laosa O, Aramburu JA, González-Herrada C, de Abajo FJ.

Pharmacogenomics. 2016 Apr;17(6):541-5. doi: 10.2217/pgs.16.10. Epub 2016 Mar 29.

PMID:
27020614
21.

Two cases of overlap severe cutaneous adverse reactions to benznidazole treatment for asymptomatic Chagas disease in a nonendemic country.

González-Ramos J, Noguera-Morel L, Tong HY, Ramírez E, Ruiz-Bravo E, Bellón T, Cabañas R, Cachafeiro L, Herranz-Pinto P.

Br J Dermatol. 2016 Sep;175(3):604-7. doi: 10.1111/bjd.14451. Epub 2016 Apr 7.

PMID:
26851874
22.

Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds.

Bellón T, Lerma V, González-Valle O, González Herrada C, de Abajo FJ.

Br J Dermatol. 2016 Mar;174(3):621-4. doi: 10.1111/bjd.14201. Epub 2015 Dec 30.

PMID:
26412570
23.

Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).

Belver MT, Michavila A, Bobolea I, Feito M, Bellón T, Quirce S.

Allergol Immunopathol (Madr). 2016 Jan-Feb;44(1):83-95. doi: 10.1016/j.aller.2015.02.004. Epub 2015 Jun 15. Review.

PMID:
26089185
24.

Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients.

Cabañas R, Calderon O, Ramirez E, Fiandor A, Prior N, Caballero T, Herránz P, Bobolea I, López-Serrano MC, Quirce S, Bellón T.

J Investig Allergol Clin Immunol. 2014;24(6):425-30.

25.

Synthesis and biological evaluation of pyridazino[1',6':1,2]pyrido[3,4-b]indolinium and pyridazino[1,6-a]benzimidazolium salts as anti-inflammatory agents.

Rodríguez-Sanz A, Sánchez-Alonso P, Bellón T, Alajarín R, Martínez-Cabeza V, Selgas R, Vaquero JJ, Álvarez-Builla J.

Eur J Med Chem. 2015 Mar 26;93:83-92. doi: 10.1016/j.ejmech.2015.01.060. Epub 2015 Jan 31.

PMID:
25659754
26.

Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production.

González-Mateo GT, Fernández-Míllara V, Bellón T, Liappas G, Ruiz-Ortega M, López-Cabrera M, Selgas R, Aroeira LS.

PLoS One. 2014 Oct 3;9(10):e108477. doi: 10.1371/journal.pone.0108477. eCollection 2014.

27.

TWEAK promotes peritoneal inflammation.

Sanz AB, Aroeira LS, Bellon T, del Peso G, Jimenez-Heffernan J, Santamaria B, Sanchez-Niño MD, Blanco-Colio LM, Lopez-Cabrera M, Ruiz-Ortega M, Egido J, Selgas R, Ortiz A.

PLoS One. 2014 Mar 5;9(3):e90399. doi: 10.1371/journal.pone.0090399. eCollection 2014.

28.

Can EPS development be avoided with early interventions? The potential role of tamoxifen--a single-center study.

De Sousa-Amorim E, Del Peso G, Bajo MA, Alvarez L, Ossorio M, Gil F, Bellon T, Selgas R.

Perit Dial Int. 2014 Sep-Oct;34(6):582-93. doi: 10.3747/pdi.2012.00286. Epub 2014 Mar 1.

29.

Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.

López-Oliva MO, Martinez V, Buitrago A, Jiménez C, Rivas B, Escuin F, Santana MJ, Selgas R, Bellón T.

Transplantation. 2014 Apr 27;97(8):839-45. doi: 10.1097/01.TP.0000438025.96334.eb.

PMID:
24345896
30.

HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis.

Genin E, Chen DP, Hung SI, Sekula P, Schumacher M, Chang PY, Tsai SH, Wu TL, Bellón T, Tamouza R, Fortier C, Toubert A, Charron D, Hovnanian A, Wolkenstein P, Chung WH, Mockenhaupt M, Roujeau JC.

Pharmacogenomics J. 2014 Jun;14(3):281-8. doi: 10.1038/tpj.2013.40. Epub 2013 Dec 10.

PMID:
24322785
31.

Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.

Lucendo AJ, Arias A, De Rezende LC, Yagüe-Compadre JL, Mota-Huertas T, González-Castillo S, Cuesta RA, Tenias JM, Bellón T.

J Allergy Clin Immunol. 2011 Nov;128(5):1037-46. doi: 10.1016/j.jaci.2011.08.007. Epub 2011 Aug 30.

PMID:
21880354
32.

The innate immune system in delayed cutaneous allergic reactions to medications.

Bellón T, Blanca M.

Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):292-8. doi: 10.1097/ACI.0b013e3283489c2c. Review.

PMID:
21659858
33.

Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.

Bellón T, Martínez V, Lucendo B, del Peso G, Castro MJ, Aroeira LS, Rodríguez-Sanz A, Ossorio M, Sánchez-Villanueva R, Selgas R, Bajo MA.

Nephrol Dial Transplant. 2011 Sep;26(9):2995-3005. doi: 10.1093/ndt/gfq771. Epub 2011 Feb 15.

PMID:
21324976
34.

Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillin-tazobactam: two case reports.

Jurado-Palomo J, Cabañas R, Prior N, Bobolea ID, Fiandor-Román AM, López-Serrano MC, Quirce S, Bellón T.

J Investig Allergol Clin Immunol. 2010;20(5):433-6.

35.

Expression of α-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions.

Morel E, Alvarez L, Cabañas R, Fiandor A, Díaz R, Escamochero S, Prior N, Blanca M, Bellón T.

Allergy. 2011 Mar;66(3):360-7. doi: 10.1111/j.1398-9995.2010.02484.x. Epub 2010 Sep 29.

PMID:
20880148
36.

CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Morel E, Escamochero S, Cabañas R, Díaz R, Fiandor A, Bellón T.

J Allergy Clin Immunol. 2010 Mar;125(3):703-10, 710.e1-710.e8. doi: 10.1016/j.jaci.2009.10.030. Epub 2010 Feb 4.

PMID:
20132973
37.

Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases.

Bellón T, Alvarez L, Mayorga C, Morel E, Torres MJ, Martín-Díaz MA, Díaz R, Radial A, Carballo M, Blanca M.

Br J Dermatol. 2010 May;162(5):1014-22. doi: 10.1111/j.1365-2133.2009.09627.x. Epub 2010 Feb 25.

PMID:
20030638
38.

Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.

Lucendo AJ, De Rezende L, Comas C, Caballero T, Bellón T.

Am J Gastroenterol. 2008 Sep;103(9):2184-93. doi: 10.1111/j.1572-0241.2008.01937.x.

PMID:
18844613
40.

The role of mast cells in eosinophilic esophagitis.

Lucendo AJ, Bellón T, Lucendo B.

Pediatr Allergy Immunol. 2009 Sep;20(6):512-8. doi: 10.1111/j.1399-3038.2008.00798.x. Epub 2008 Aug 4. Review.

PMID:
18681944
41.

Acute generalized exanthematous pustulosis due to tetrazepam.

Thomas E, Bellón T, Barranco P, Padial A, Tapia B, Morel E, Alves-Ferreira J, Martín-Esteban M.

J Investig Allergol Clin Immunol. 2008;18(2):119-22.

42.

Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.

Tapia B, Morel E, Martín-Díaz MA, Díaz R, Alves-Ferreira J, Rubio P, Padial A, Bellón T.

Clin Exp Allergy. 2007 May;37(5):704-13.

PMID:
17456218
44.

Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j.

Sayós J, Martínez-Barriocanal A, Kitzig F, Bellón T, López-Botet M.

Biochem Biophys Res Commun. 2004 Nov 12;324(2):640-7.

PMID:
15474475
45.

Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.

Tapia B, Padial A, Sánchez-Sabaté E, Alvarez-Ferreira J, Morel E, Blanca M, Bellón T.

J Allergy Clin Immunol. 2004 Aug;114(2):335-40.

PMID:
15316512
46.

Signalling via CD70, a member of the TNF family, regulates T cell functions.

García P, De Heredia AB, Bellón T, Carpio E, Llano M, Caparrós E, Aparicio P, López-Botet M.

J Leukoc Biol. 2004 Jul;76(1):263-70.

PMID:
15226368
47.

Skin test evaluation in nonimmediate allergic reactions to penicillins.

Torres MJ, Sánchez-Sabaté E, Alvarez J, Mayorga C, Fernández J, Padial A, Cornejo-García JA, Bellón T, Blanca M.

Allergy. 2004 Feb;59(2):219-24.

PMID:
14763937
48.

Acute generalized exanthematous pustulosis associated with pseudoephedrine.

Padial MA, Alvarez-Ferreira J, Tapia B, Blanco R, Mañas C, Blanca M, Bellón T.

Br J Dermatol. 2004 Jan;150(1):139-42.

PMID:
14746629
49.

Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones.

Brostjan C, Bellón T, Sobanov Y, López-Botet M, Hofer E.

J Immunol Methods. 2002 Jun 1;264(1-2):109-19.

PMID:
12191515
50.

Supplemental Content

Loading ...
Support Center